¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Norepinephrine Plasma Membrane Transport Proteins"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plasma hemoglobin
    Ç÷ÀåÇ÷»ö¼Ò
  • plasma iron
    Ç÷Àåö
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü
  • plasma iron turnover rate
    Ç÷Àåö±³Ã¼À²
  • plasma pepsinogen
    Ç÷ÀåÆé½Ã³ë°Õ
  • plasma substitute
    Ç÷Àå´ëüÁ¦
  • plasma thromboplastin factor
    Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
  • plasma volume expander
    Ç÷ÀåÁõ·®Á¦
  • pooled blood plasma
    È¥ÇÕÇ÷Àå
  • seminal plasma
    Á¤¾×Àå¾×
  • arachnoid membrane
    °Å¹Ì¸·, ÁöÁÖ¸·
  • atlanto-occipital membrane
    °í¸®µÚÅë¼ö¸·, ȯÃßÈĵθ·
  • acrosomal membrane
    ÷´Üü¸·
  • alveolar-capillary membrane
    ÆóÆ÷¸ð¼¼Ç÷°ü¸·, ÇãÆÄ²Ê¸®¸ð¼¼Ç÷°ü¸·
  • amnionic membrane
    ¾ç¸·
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • virginal membrane
    (¢¡hymen) ó³à¸·
  • premature rupture of membrane
    Á¶±â¾ç¸·ÆÄ¼ö, Á¶±â¾ç¸·ÆÄ¿­
  • membrane potential
    ¸·ÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plasma volume expander
    ÀΰøÇ÷ÀåÁõ·®Á¦
  • plasma coagulation factor
    Ç÷ÀåÀÀ°íÀÎÀÚ
  • plasma thromboplastin factor
    Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
  • plasma cell granuloma
    ÇüÁú¼¼Æ÷À°¾ÆÁ¾
  • plasma hemoglobin
    Ç÷ÀåÇ÷¾×¼Ò
  • plasma iron
    Ç÷Àåö
  • plasma cell mastitis
    ÇüÁú¼¼Æ÷À¯¹æ¿°
  • plasma cell myeloma
    ÇüÁú¼¼Æ÷°ñ¼öÁ¾
  • plasma cross matching
    (¢¡cross matching) Ç÷Àå±³Â÷½ÃÇè
  • plasma
    Ç÷Àå, ¿øÇüÁú, ¼¼Æ÷Áú
  • plasma pepsinogen
    Ç÷ÀåÆé½Ã³ë°Õ
  • plasma substitute
    Ç÷Àå´ëÄ¡Á¦
  • plasma component transfusion
    Ç÷À强ºÐ¼öÇ÷
  • plasma iron pool
    Ç÷ÀåöÀúÀå°í
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plasma cell dyscrasia
    ÇüÁú¼¼Æ÷ÀÌȥȭÁõ
  • plasma cell dyscrasia
    ÇüÁú¼¼Æ÷Áúȯ(û¡òõá¬øàòðü´), ÇüÁú¼¼Æ÷Àå¾Ö(¡­î¡äô), ÇüÁú¼¼Æ÷ÀÌȥȭÁõ(¡­ì¶ûèûúñø)
  • plasma cell gingivostomatitis
    ÇüÁú¼¼Æ÷ Ä¡Àº ±¸³»¿°
  • plasma cell leukemia
    ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´
  • plasma cell leukemia
    ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´(û¡òõá¬øààõ ÛÜúìÜ»)
  • plasma cell leukemia
    ÇüÁú¼¼Æ÷ ¹éÇ÷º´
  • plasma cell mastitis
    ÇüÁú¼¼Æ÷¼ºÀ¯¹æ¿°(û¡òõá¬øààõêáÛ®æú)
  • plasma cell myeloma
    ÇüÁú¼¼Æ÷ °ñ¼öÁ¾
  • plasma cell myeloma
    ÇüÁú¼¼Æ÷°ñ¼öÁ¾(û¡òõá¬øàÍéâÐðþ)
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼º Æó·Å.
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼ºÆó·Å(û¡òõá¬øààõøËæú)
  • plasma cell tumor
    ÇüÁú¼¼Æ÷Á¾¾ç
  • plasma cell vulvitis
    ÇüÁú¼¼Æ÷ ¿©¼ºÀ½ºÎ¿°
  • plasma clot
    Ç÷À屫.
  • plasma clot
    Ç÷À屫(úìíìÎÔ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • facilitated transport
    ÃËÁø¼ö¼Û(¡­âÃáê).
  • gas transport
    °¡½º¿î¹Ý(ê¡Úæ).
  • glucose transport protein unit
    Æ÷µµ´ç ¿î¹Ý ´Ü¹é ´ÜÀ§(GLUT)
  • lipid transport
    ÁöÁú¿î¼Û
  • medium, transport
    ¼ö¼Û¹èÁö
  • net transport
    ¼ø¿î¹Ý.
  • oxygen transport
    »ê¼Ò¿î¹Ý(¡­¿î¹Ý).
  • oxygen transport
    »ê¼Ò¿î¹Ý(¡­ê¡Úæ).
  • oxygen transport mechanism
    »ê¼Ò¿î¹Ý ±âÀü.
  • passive transport
    Çǵ¿Àû ¿î¹Ý(¡­ê¡Úæ).
  • piece, transport
    ¿î¹Ý¼ººÐ, ¼ö¼Û¼ººÐ
  • sodium transport system
    ³ªÆ®·ý¿î¹Ý°è (¡­ê¡ÚæÍ§).
  • specimen transport
    °Ëü¼ö¼Û
  • supersonic transport
    ÃÊÀ½ÆÄ¼ö¼Û(¡­âÃáê).
  • symport= co- transport
    °øµ¿¿î¹Ý(ÍìÔÒê¡Úæ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Tectorial membrane
    µ¤°³¸·
    [¿¾ ¿ë¾î] Çǰ³¸·
  • Pupillary membrane
    µ¿°ø¸·
    [¿¾ ¿ë¾î] µ¿°ø¸·
  • Secondary tympanic membrane
    µÑ°°í¸·
    [¿¾ ¿ë¾î] Á¦ÀÌ°í¸·
  • Seconday tympanic membrane
    µÑ°°í¸·
    [¿¾ ¿ë¾î] Á¦2°í¸·
  • Descemet`s membrane
    µÚ°æ°èÆÇ
    [¿¾ ¿ë¾î] Èİæ°èÆÇ(Descemet¸·)
  • Posterior limiting membrane
    µÚ°æ°èÆÇ
    [¿¾ ¿ë¾î] Èİæ°èÆÇ
  • Posterior atlanto-occipital membrane
    µÚ°í¸®µÚÅë¼ö¸·
    [¿¾ ¿ë¾î] ÈÄȯÃßÈĵθ·
  • Stapedial membrane
    µîÀÚ¸·
    [¿¾ ¿ë¾î] µî°ñ¸·
  • External intercostal membrane
    ¹Ù±ù°¥ºñ»çÀ̸·
    [¿¾ ¿ë¾î] ³úÃø°£¸·
  • External intercostal membrane
    ¹Ù±ù°¥ºñ»çÀ̸·
    [¿¾ ¿ë¾î] ¿Ü´Á°£¸·
  • Outer limiting membrane
    ¹Ù±ù°æ°èÃþ
    [¿¾ ¿ë¾î] ¿Ü°æ°èÃþ
  • External mitochondrial membrane
    ¹Ù±ù»ç¸³Ã¼¸·
    [¿¾ ¿ë¾î] »ç¸³Ã¼¿Ü¸·
  • External glial limiting membrane
    ¹Ù±ù¾Æ±³°æ°è¸·
    [¿¾ ¿ë¾î] ¿Ü±³°æ°è¸·
  • External acrosomal membrane
    ¹Ù±ù÷´Üü¸·
    [¿¾ ¿ë¾î] ÷´Üü¿Ü¸·
  • Outer acrosomal membrane
    ¹Ù±ù÷´Üü¸·
    [¿¾ ¿ë¾î] ¿Ü÷´Üü¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plasma thromboplastic factor B
    Ç÷Àå Ç÷ÀüÇü¼ºÀÎÀÚ B
  • plasma thromboplastin antecedent
    Ç÷Àå(úìíì) Æ®·Òº¸ÇÃ¶ó½ºÆ¾ Àü±¸¹°(îñÏÌÚª)
  • plasma thromboplastin component
    Ç÷Àå(úìíì) Æ®·Òº¸ÇÃ¶ó½ºÆ¾ ¼ººÐ(à÷ÝÂ)
  • plasma transferrin
    Ç÷Àå(úìíì) Æ®¶õ½ºÆä¸°
  • plasma transglutaminase
    Ç÷Àå(úìíì) Æ®¶õ½º±Û·çŸ¹Ì³×À̽º
  • separated plasma
    ºÐ¸®Ç÷Àå(ÝÂ×îúìíì)
  • sex steroid binding plasma protein
    ¼º(àõ)½ºÅ×·ÎÀÌµå °áÇÕ(Ì¿ùê) Ç÷Àå(úìíì) ´Ü¹éÁú(úìíìÓ±ÛÜòõ)
  • true plasma
    ¼øÇ÷Àå(âíúìíì)
  • whole plasma
    ÀüÇ÷Àå(îïúìíì)
  • bare lipid membrane
    ¾Ë¸ö ÁöÁú¸·(ò·òõد)
  • bilayer lipid membrane
    ¾çÃþ ÁöÁú¸·(å»öµ ò·òõد)
  • bileaflet membrane
    ÀÌÁß¼Ò¿±¸·(ì£ñìá³ç¨Ø¯)
  • bimolecular lamellar lipid membrane
    À̺ÐÀÚ(ì£ÝÂí­) ÆÇ»óÁöÁú¸·(÷ùßÒò·òõد)
  • bimolecular lipid membrane
    À̺ÐÀÚ ÁöÁú¸·(ì£ÝÂí­ò·òõد)
  • black lipid membrane
    Èæ ÁöÁú¸·(ýÙò·òõد)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
f-NE free norepinephrine
NE national emergency; necrotic enteritis; necrotizing enterocolitis; nephropathia epidemica; nerve end...
NET nasoendotracheal tube; nerve excitability test; neuroectodermal tumor; neuroendocrine tumor; norepin...
NOR-EPI norepinephrine
t-NE total norepinephrine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NEpi Norepinephrine
NOR Norepinephrine
hNET human norepinephrine transporter
[NE] norepinephrine concentration
SNRI serotonin norepinephrine reuptake inhibitor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • plasma thromboplastin antecedent deficiency
    PTA °áÇÌÁõ
  • pooled plasma
    È¥ÁÖ Ç÷Àå
  • renal plasma flow
    ½Å Ç÷Àå·ù, ½Å Ç÷Àå·ù·®
  • venous plasma blood glucose
    Á¤¸Æ Ç÷Àå Ç÷´çÄ¡, Á¤¸Æ Ç÷Àå Ç÷´ç
  • antibasement membrane antibody
    Ç×±âÀú¸· Ç×ü
  • arachnoid membrane
    °Å¹Ì¸·
    ³ú¿Í ô¼ö¸¦ µÑ·¯½Ñ ¼¼ ÃþÀÇ ¸· Áß Áß°£Ãþ.
  • autoantibody against basement membrane
    Ç×±âÀú¸· ÀÚ°¡ Ç×ü
  • basal membrane of semicircular canal
    ¹Ý±Ô°ü ±âÀú¸·, ¹Ý°í¸®°ü ¹Ù´Ú ¸·
  • basilar membrane
    ±âÀú ¸·
  • benign mucous membrane pemphigoid
    ¾ç¼º Á¡¸· À¯ÃµÆ÷â
  • biological membrane
    »ýü ¸·
    ¼¼Æ÷ ¶Ç´Â ¼¼Æ÷ ¼Ò±â°üÀÇ °ÑÀ» ½Î°í ÀÖ´Â ¸·. ¹Ì»ý¹°, ½Ä¹°, µ¿¹°ÀÇ ¼¼Æ÷¸·°ú ¿±·Ïü, ¹ÌÅäÄܵ帮¾ÆÀÇ ³», ¿Ü¸·, °ñÁöü, ¼ÒÆ÷ü ¸·, ÇÙ¸· µîÀÌ º¸±âÀÌ´Ù. »ýü¸·ÀÇ ±¸Á¶¿¡ °üÇÑ ¸ðµ¨Àº ¿©·¯ °¡Áö°¡ Á¦½ÃµÇ¾úÀ¸³ª °áÁ¤ÀûÀÎ °ÍÀº ¾ø´Ù. ¿ª»çÀûÀ¸·Î º¼ ¶§ J.F. ´Ù´Ï¿¤ ¸®°¡ Á¦Ã¢Çϰí J.D. ·Î¹öÆ®½¼¿¡ ÀÇÇØ ¼öÁ¤µÈ ´ÜÀ§¸· ¸ðµ¨ÀÌ ÀÖÀ¸¸ç, ±× ÈÄ B. º¥¼Õ µî¿¡ ÀÇÇØ Á¦Ã¢µÈ ¹Ýº¹ ´ÜÀ§ ¸ðµ¨ÀÌ ÀÖ´Ù. ÇöÀç ³Î¸® ÀÎÁ¤¹Þ°í ÀÖ´Â °ÍÀ¸·Î´Â 1972³â S.J. ½Ì°Å µîÀÌ Á¦Ã¢ÇÑ À¯µ¿ ¸ðÀÚÀÌÅ© ¸ðµ¨ÀÌ ÀÖ´Ù. ¸·ÀÇ ÁÖ ¼ººÐÀº ´Ü¹éÁú°ú ÁöÁúÀÌ¸ç µÎ ¼ººÐÀÇ Áß·®ºñ´Â 3:2~3:1·Î ´Ü¹éÁúÀÌ ¸¹´Ù. ÁöÁúÀÇ ÁÖ ¼ººÐÀº ÀÎÁöÁúÀÌ¸ç »ýü¸·ÀÇ ¼ººÐÀ¸·Î ´Ù´ç·ùµµ ¾à°£ Á¸ÀçÇÑ´Ù. ¸·ÀÇ ±¸¼º ¼ººÐÀÎ ÀÎÁöÁú ºÐÀÚ´Â ÀϺκп¡ Ä£¼ö¼º±â¸¦ °¡Áø °¡´À´Ù¶õ ºÐÀڷμ­, ±× ±ä ÃàÀÌ ¸·¸é°ú Á÷°¢À¸·Î ´Ã¾î¼­ ÀÖ°í ¼Ò¼ö¼º ºÎºÐÀÌ ¸¶ÁÖº¸°í ÀÖ¾î 2ºÐÀÚ µÎ²²ÀÇ ¸·À» ¸¸µç´Ù. ´Ü¹éÁúÀº ÁÖ·Î ±¸»ó ´Ü¹éÁúÀ̸ç, ÀÌ ÁöÁú ÀÌÁßÃþ ¼Ó¿¡ ´Ü¹éÁúÀÇ ¼Ò¼ö¼º ºÎºÐÀÌ Àá°Ü ÀÖµíÀÌ Á¸ÀçÇÑ´Ù. ¾î¶² °ÍÀº ¸·ÀÇ ¾ç¸é¿¡ ºÐÀÚÀÇ ÀϺκÐÀ» µå·¯³»°í ÀÖ´Ù. ÀÌ °á°ú ¸·Àº ÁöÁú°ú ´Ü¹éÁúÀÌ ¸ðÀÚÀÌÅ© »óÀ¸·Î Á¸ÀçÇÏ´Â ±¸Á¶°¡ µÈ´Ù. ÁöÁúÀº »ý¸®Àû ¿Âµµ¿¡¼­´Â ¾×üÀ̱⠶§¹®¿¡ ¸· ¼ººÐÀÎ ´Ü¹éÁúÀº ºñ±³Àû ÀÚÀ¯·Ó°Ô ¸·³»¸¦ À̵¿
  • bowmans membrane
    ¾Õ°æ°èÆÇ
  • bucconasal membrane
    ±¸ºñ¸·
  • buccopharyngeal membrane
    ÇùÀεΠ¸·
  • cell membrane permeability
    ¼¼Æ÷¸· Åõ°ú¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
nuclear transport <cell biology> Passage of molecules in and out of the nucleus, presumably via nuclear pores. Passage of proteins into the nucleus may depend on possession of a nuclear location sequence containing five consecutive positively charged residues PKKKRKV).
(18 Nov 1997)
nucleocytoplasmic transport <cell biology, molecular biology> Transport of molecules from the nucleus to the cytoplasm.
(18 Nov 1997)
iodide transport defect See: familial goiter.
(05 Mar 2000)
ion transport The movement of ions across energy-transducing cell membranes. Transport can be active or passive. Passive ion transport (facilitated diffusion) derives its energy from the concentration gradient of the ion itself and allows the transport of a single solute in one direction (uniport). Active ion transport is usually coupled to an energy-yielding chemical or photochemical reaction such as ATP hydrolysis. This form of primary active transport is called an ion pump. Secondary active transport utilises the voltage and ion gradients produced by the primary transport to drive the cotransport of other ions or molecules. These may be transported in the same (symport) or opposite (antiport) direction.
(12 Dec 1998)
orthograde transport Axonal transport from the cell body of the neuron towards the synaptic terminal. Opposite of retrograde transport and probably dependent on a different mechanochemical protein (almost definitely kinesin) interacting with microtubules.
(18 Nov 1997)
ovum transport Transport of the ovum or zygote from the site of ovulation to the site of implantation.
(12 Dec 1998)
electron transport The transport of electrons through a number of electron carriers in a set sequence.
(09 Oct 1997)
electron transport chain <biochemistry, chemistry> A series of compounds that transfer electrons to an eventual donor with concomitant energy conversion.
One of the best studied is in the mitochondrial inner membrane, that takes NADH (from the tricarboxylic acid cycle) or FADH and transfers electrons via ubiquinone, cytochromes and various other compounds, to oxygen. Other electron transport chains are involved in photosynthesis.
(18 Nov 1997)
electron transport particles <cell biology> Fragments of mitochondria still capable of transporting electrons.
One of the units occurring on the matrical surface of mitochondrial cristae; the head of the particle which measures about 9 nm, attaches to the membrane of the crista by a stalk 5 nm in length; the particle may be concerned with the electron transport system.
Synonym: submitochondrial particles.
(05 Mar 2000)
electron transport phosphorylation <biochemistry> Synthesis of ATP involving a membrane associated electron transport chain and the creation of a proton-motive force.
(09 Oct 1997)
electron transport system The mitochondrial electron transport chain.
(18 Nov 1997)
transcellular transport Solute movement across an epithelial cell layer through the cells.
Compare: paracellular transport.
(05 Mar 2000)
transport <radiobiology> Refers to processes which cause heat energy, or particles, or something else, to flow out of the plasma and cease being confined. Diffusion partly determines the rate of transport. Energy losses from a plasma due to transport processes are a central problem in fusion energy research.
See: classical transport, neoclassical transport, anomalous tranport, diffusion, ambipolar diffusion, Bohm diffusion, classical diffusion, neoclassical diffusion, anomalous diffusion, energy transport, ripple transport.
(09 Oct 1997)
transport antibiotic A substance that makes biomembranes permeable to certain ions.
(05 Mar 2000)
transport diseases Single gene defect diseases in which there is an inability to transport particular small molecules across membranes.
Examples are aminoacidurias such as cystinuria, iminoglycinuria, Hartup disease, Fanconi disease.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á